Cart
sales@molnova.com
Bevenopran
CAS No. 676500-67-7
Bevenopran( CB-5945 | ADL-5945 )
Catalog No. M26628 CAS No. 676500-67-7
Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 145 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 198 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 551 | In Stock |
|
| 200MG | 728 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBevenopran
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
-
DescriptionBevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.(In Vivo):Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.
-
In Vitro——
-
In VivoBevenopran is a peripheral μ-opioid receptor antagonist. Bevenopran is currently under investigation for the treatment of opioid-induced bowel dysfunction (OBD). Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.
-
SynonymsCB-5945 | ADL-5945
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorAcidic mammalian chitinase (AMCase)| Chitotriosidase (CHIT1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number676500-67-7
-
Formula Weight386.452
-
Molecular FormulaC20H26N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (323.47 mM)
-
SMILESCOc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(cn1)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Robert Koralewski, et al. Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis. J Med Chem. 2020 Dec 24;63(24):15527-15540.
molnova catalog
related products
-
Naltrexone
A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of 0.0825 nM, 0.509 nM, and 8.02 nM, for MOR, KOR, and DOR, respectively.
-
Naloxone hydrochlori...
Naloxone hydrochloride is an opioid inverse agonist drug used to counter the effects of opiate overdose.
-
(20R)-Protopanaxdiol
Protopanaxdiol has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity.
